Oxolipidomics profile in major depressive disorder: Comparing remitters and non-remitters to repetitive transcranial magnetic stimulation treatment.

Oxolipidomics profile in major depressive disorder: Comparing remitters and non-remitters to repetitive transcranial magnetic stimulation treatment.

<h4>Background</h4>Repetitive Transcranial Magnetic Stimulation [rTMS] is increasingly being used to treat Major Depressive Disorder [MDD]. Given that not all patients respond to rTMS, it would be clinically useful to have reliable biomarkers that predict treatment response. Oxidized pho...

Full description

Bibliographic Details
Main Authors: Hannah Stirton, Benjamin P Meek, Andrea L Edel, Zahra Solati, Arun Surendran, Harold Aukema, Mandana Modirrousta, Amir Ravandi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0246592

Internet

https://doi.org/10.1371/journal.pone.0246592

Similar Items